RACHEL NOTARESCHI: Open Payments
NPI 1174191027 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,805 in 92 payments from 36 companies in 2025. Trend: 2023 $1,387 · 2024 $1,815 · 2025 $1,805
Food & beverage: $1,805
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $182 |
| Merck Sharp & Dohme LLC | 7 | $138 |
| Novartis Pharmaceuticals Corporation | 5 | $134 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $127 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $108 |
| Incyte Corporation | 5 | $107 |
| Regeneron Healthcare Solutions, Inc. | 5 | $106 |
| BeOne Medicines USA, Inc. | 4 | $77 |
| Genentech USA, Inc. | 4 | $75 |
| AstraZeneca Pharmaceuticals LP | 4 | $74 |
Products named: Nubeqa, KEYTRUDA, FRUZAQLA, KISQALI, REBLOZYL, BRUKINSA, Epkinly, LIBTAYO.
Industry payments across AL — which companies pay providers there.
